Keywords: آنتی بادی مهار شده رد; Urinary cell mRNA profiling; Polymerase chain reaction; Rejection; Tolerance; Kidney transplantation; mRNA; messenger RNA; RT-QPCR; real-time quantitative PCR; ACR; acute cellular rejection; ROC; receiver-operating-characteristic; PI-9; proteinase inhibit
مقالات ISI آنتی بادی مهار شده رد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادی مهار شده رد; ABMR; Antibody mediated rejection; aHUS; Atypical hemolytic syndrome; AP; Alternative pathway; DBD; Deceased brain dead; DCD; Deceased cardiac death; DSA; Donor specific antibodies; C1-INH; C1-inhibitor; C3; Complement component C3; CDC; Complement-depend
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; DSA; donor specific antibodies; HLA; human leukocyte antigen; MFI; median fluorescence intensity; PRA; panel reactive antibody; PTC; peritubular capillaries; SAB; single-antigen bead; TG; transplant glomerulopathy; Acute
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; BAL; broncho-alveolar lavage; BOS; bronchiolitis obliterans syndrome; CLAD; chronic lung allograft syndrome; CT; computed tomography; DSA; donor specific antibodies; FEV1; forced expiratory volume in 1Â s; FVC; forced vit
Keywords: آنتی بادی مهار شده رد; Liver transplantation; Machine perfusion; Recurrent disease; Donation after circulatory; Death; De novo cancer; AIH; autoimmune hepatitis; AMR; antibody mediated rejection; BMI; body metabolic index; HBV; hepatitis B Virus; CMV; cytomegalovirus; DBD; dona
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; AVA; anti-vimentin antibodies; CFA; complete Freund's adjuvant; HMEC; human microvascular endothelial cells; MMF; mycophenolate mofetil; PAF; platelet activating factor;
Keywords: آنتی بادی مهار شده رد; AMR; antibody-mediated rejection; RBCT; red blood cell transfusion; cPRA; calculated panel reactive antibody; DSA; donor specific antibodies; DGF; delayed graft function; BPAR; biopsy proven acute rejection; MFI; mean fluorescence intensity; SAB; single a
Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies
Keywords: آنتی بادی مهار شده رد; Kidney transplant; Deceased donor; Acute rejection; Donor-specific antibodies; HLA-antibodies; %PRA; panel reactive antibody percentage; AMR; antibody mediated rejection; ACR; acute cellular rejection; AR; acute rejection; CDC; complement-dependent cytoto
Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
Keywords: آنتی بادی مهار شده رد; ABOi; ABO incompatible; AECA; anti endothelial cell antibody; AMR; antibody mediated rejection; AT1R; angiotensin II type 1 receptor; AT1R-Ab; anti-angiotensin II type 1 receptor antibody; HLA-DSA; donor specific HLA antibody; HLAi; HLA incompatible; ECXM
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation
Keywords: آنتی بادی مهار شده رد; donor specific antibodies; antibody mediated rejection; heart transplantation; transplant outcomes; transplant disparity;
Soluble Major Histocompatibility Complex Class I related Chain A (sMICA) levels influence graft outcome following Renal Transplantation
Keywords: آنتی بادی مهار شده رد; Soluble MICA; Kidney transplantation; Acute cellular rejection; Antibody mediated rejection; Sandwich ELISA;
Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies
Keywords: آنتی بادی مهار شده رد; DSA; donor specific antibodies; Abs; antibodies; SAB; Single Antigen Bead; PE; plasma exchange; IA; immunoadsorption; ABMR; Antibody Mediated Rejection; DTT; Dithiothreitol; MFIOL; MFI obtained with One Lambda Single-Antigen Bead Assay; MFIIM; MFI obtaine
Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation
Keywords: آنتی بادی مهار شده رد; antibody mediated rejection; donor specific antibodies; heart transplant; cardiac allograft vasculopathy; mortality;
Accelerated humoral renal allograft rejection due to HLA-C14 mediated allosensitization to HLA-Bw6
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; AHG; anti-human globulin; ATG; anti-thymocyte globulin; CDCXM; complement-dependent cytotoxicity crossmatch; CMV; cytomegalovirus; DSA; donor specific antibody; DTT; dithiothreitol; EBV; Epstein-Barr Virus; EDTA; ethylene
Immunogenicity of Class I HLA but not preformed low MFI donor specific antibodies correlates with outcomes after first renal transplantation
Keywords: آنتی بادی مهار شده رد; AAR; amino acid residue; AbVer; antibody verified; ACR; acute cellular rejection; AMR; antibody mediated rejection; DE; deleterious effect; DSA; donor specific antibodies; FC CM; flow cytometry cross match; KTR; kidney transplant recipient; MFI; mean fluo
New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist
Keywords: آنتی بادی مهار شده رد; ACR; acute cellular rejection; AMR; antibody mediated rejection; ATN; acute tubular necrosis; cPRA; calculated panel reactive antibody; DGF; delayed graft function; DSA; donor specific antibody; KAS; Kidney Allocation System; EPTS; estimated post transpla
High expression of TIM-3 and KIM-1 in blood and urine of renal allograft rejection patients
Keywords: آنتی بادی مهار شده رد; ESRD; end-stage renal disease; PBMC; peripheral blood mononuclear cell; WFG; well-functioning graft; AD; acute rejection; CAD; chronic allograft dysfunction; ABMR; antibody mediated rejection; TCMR; T cell mediated rejection; BL; borderline; ATN; acute tu
Understanding solid-phase HLA antibody assays and the value of MFI
Keywords: آنتی بادی مهار شده رد; MFI; mean fluorescence intensity; HLA; human leukocyte antigen; SAB; single antigen bead; DSA; donor-specific antibody; AMR; antibody mediated rejection; cPRA; calculated PRA; EDTA; Ethylenediaminetetraacetic acid; DTT; Dithiothreitol; PE; phycoerythrin;
Rechazo agudo del trasplante renal: diagnóstico y alternativas terapéuticas
Keywords: آنتی بادی مهار شده رد; Rechazo agudo; Rechazo mediado por Anticuerpos; Trasplante renal; Acute rejection; Antibody mediated rejection; Renal transplantation;
Circulating angiotensin type II receptor: Possible marker for antibody mediated rejection after renal transplantation?
Keywords: آنتی بادی مهار شده رد; Antibody mediated rejection; AT1R; Donor specific antibody; Renal transplantation;
Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival
Keywords: آنتی بادی مهار شده رد; KIRs; killer cell immunoglobulin-like receptors; NK; natural killer; HLA; human leukocyte antigen; LRC; leukocyte receptor complex; IPD-KIR; immuno polymorphism database for KIR; HCV; hepatitis C virus; HIV; human immunodeficiency virus; HSCT; hematopoiet
B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantation
Keywords: آنتی بادی مهار شده رد; BAFF; Allograft rejection; Viral infection; Antibody mediated rejection; Steroid resistance; Allograft function;
Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; ATG; anti-thymocyte globulin; AT1R; angiotensin II type 1 receptor; AT1Rab; angiotensin II type 1 receptor antibody; AUC; area under the curve; CDC; complement dependent cytotoxicity; DSA; donor specific antibody; HLA; hu
Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection
Keywords: آنتی بادی مهار شده رد; Ab; antibody; ABTS; 2,2â²-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid); ADCC; antibody dependent cell-mediated cytotoxicity; AMR; antibody mediated rejection; ATG; Anti ThymoGlobulin; CHR; chronic humoral rejection; DC-SIGN; dendritic cell-specific
Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs
Keywords: آنتی بادی مهار شده رد; AMR; Antibody mediated rejection; CIITA; Class II Transactivator; CLIP; Class II associated invariant peptide; dnDSA; De novo Donor HLA Specific Antibodies; DSA; Donor HLA Specific Antibodies; IFNÆ´; Interferon gamma; Ii; Invariant chain; MAC; Membrane At
De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome
Keywords: آنتی بادی مهار شده رد; lung transplantation; de-novo donor-specific antibodies; antibody mediated rejection; chronic lung allograft dysfunction; survival;
Pregnancy-induced HLA antibodies respond more vigorously after renal transplantation than antibodies induced by prior transplantation
Keywords: آنتی بادی مهار شده رد; ATG; anti-thymocyte globulin; CDC; complement dependent cytotoxicity; DSA; donor specific antibody; FC; flow cytometry; IQR; interquartile range; MFI; mean fluorescence intensity; HLA antibodies; Antibody incompatible kidney transplantation; Antibody medi
Donor non-specific MICA antibodies in renal transplant recipients
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; HLA; human leukocyte antigen; MICA; major histocompatibility complex class I chain-related gene A; NK; natural killer; Antibodies against MICA; Kidney transplantation; MICA antibody specificities; MICA alleles;
Humoral immunity in hand transplantation: Anti-HLA and non-HLA response
Keywords: آنتی بادی مهار شده رد; Hand transplantation; Anti-HLA antibodies; Non-HLA antibodies; Antibody mediated rejection
The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes
Keywords: آنتی بادی مهار شده رد; Non-HLA antibodies; ETAR Abs; Humoral rejection; Renal transplant injury; Renal transplantation; Antibody mediated rejection;
Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation
Keywords: آنتی بادی مهار شده رد; AMR; Antibody Mediated Rejection; CMR; Cell Mediated Rejection; DSA; Donor Specific Antibody; FXM; Flow Crossmatch; MFI; Mean Fluorescence Intensity; CDC-XM; Complement Dependent Cytotoxicity Crossmatch; PTC; Peritubular Capillaries; SAFB; Single Antigen
Clinical evaluation of the endothelial tie-2 crossmatch in ABO compatible and ABO incompatible renal transplants
Keywords: آنتی بادی مهار شده رد; ADCC; antibody dependent cell cytotoxicity; EC; endothelial cell; PEC; precursor endothelial cell; RTx; renal transplantation; IS; immunosuppression; MPA; mycophenolate acid; mTORi; mammalian target of rapamycin; PP; plasmapharesis; IVIg; intravenous immu
Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection
Keywords: آنتی بادی مهار شده رد; Ab; antibody; AEC; airway epithelial cells; Ag; antigen; AGTR1; angiotensin II type 1 receptor; AMR; antibody mediated rejection; APC; antigen presenting cell; BOS; bronchiolitis obliterans syndrome; CAN; chronic allograft nephropathy; CAV; cardiac allogr
Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; anti-HLA; antibodies to human leukocyte antigen; anti-IgG-PE; antihuman-IgG-conjugated phycoerythrin; CDC; complement dependent cytotoxicity; CV; coefficient of variation; DSA; donor specific antibody; Mayo; Mayo Clinic R
Therapeutic apheresis in transplantation medicine, experience with cardiac and lung transplantation in Jena
Keywords: آنتی بادی مهار شده رد; Apheresis; Antibody mediated rejection; Heart transplantation; Immunoadsorption; Lipoprotein apheresis; Lung transplantation; Plasma exchange
Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation
Keywords: آنتی بادی مهار شده رد; pediatric; heart transplant; C4d; antibody mediated rejection; alloantibody;
Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients
Keywords: آنتی بادی مهار شده رد; HLA antibody; complement binding; antibody mediated rejection; heart transplantation; virtual crossmatch;
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation
Keywords: آنتی بادی مهار شده رد; heart; antibody mediated rejection; immunohistochemistry; immunofluorescence; intravascular; activated mononuclear cells; complement;
Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction
Keywords: آنتی بادی مهار شده رد; Lung transplantation; Autoimmunity; IL-17; Antibody mediated rejection; Obliterative bronchiolitis; Primary graft dysfunction
Proteasome inhibition by bortezomib: Effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation
Keywords: آنتی بادی مهار شده رد; AMR; antibody mediated rejection; ATG; antithymocyte globulin; CDC; complement-dependent lymphocytotoxic; HLA; human leucocyte antigen; Ig; immunoglobulin; IL; interleukin; IVIG; intravenous immunoglobulin; MFI; mean fluorescence intensity; PRA; panel rea
Treatment options and strategies for antibody mediated rejection after renal transplantation
Keywords: آنتی بادی مهار شده رد; Antibody mediated rejection; Transplantation; Desensitization; Treatment; Plasma cell
B cells in cardiac transplants: From clinical questions to experimental models
Keywords: آنتی بادی مهار شده رد; Antibody mediated rejection; Complement activation; Endocardial lymphoid nodules; Tertiary lymphoid organogenesis; Perivascular adipose tissue
Immune monitoring of pediatric heart transplant recipients through serial donor specific antibody testing — An initial experience and review of the literature
Keywords: آنتی بادی مهار شده رد; Donor specific antibodies; Antibody mediated rejection; Cardiac allograft vasculopathy; Allosensitization; Heart transplantation
Endothelitis in cardiac allograft biopsy specimens: Possible relationship to antibody-mediated rejection
Keywords: آنتی بادی مهار شده رد; heart transplantation; antibody mediated rejection; endothelitis; vasculitis; complement;
Humoral immunity and antibody-mediated rejection in solid organ transplantation
Keywords: آنتی بادی مهار شده رد; Humoral rejection; Antibody mediated rejection; ABO incompatible; Positive crossmatch; HLA antibody; Anti-endothelial antibody;
Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantat
Keywords: آنتی بادی مهار شده رد; MICA; HLA; Cardiac transplantation; Antibody mediated rejection; Cardiac allograft vasculopathy;
Deposition of C4d and C3d in cardiac transplants: A factor in the development of coronary artery vasculopathy
Keywords: آنتی بادی مهار شده رد; coronary artery vasculopathy; antibody mediated rejection; complement; cardiac transplant; myocardial biopsy;
Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy
Keywords: آنتی بادی مهار شده رد; myosin; vimentin; self-antigens; antibody mediated rejection; cardiac allograft vasculopathy;
Cross Reactive Epitope Group antibodies in sensitized kidneys transplant recipients was associated with early acute Antibody Mediated Rejection
Keywords: آنتی بادی مهار شده رد; Antibody Mediated Rejection; Cross Reactive Epitope Group (CREG); Renal transplant
Alloantibodies and the Outcome of Cadaver Kidney Allografts
Keywords: آنتی بادی مهار شده رد; antiHLA antibodies; flow cytometry cross-matches; antibody mediated rejection; C4d deposition